Synopsis
We understand that registering for a conference is not essential right now and many researchers will be unable to register for a future conference of interest if their university or lab is temporarily closed. Therefore, you can simply register your interest here to be kept updated with details about this conference without committing to attending and our team will keep in touch with you regarding deadline reminders and grant opportunities. If you are looking to register to take advantage of the earlybird deadline or if you wish to submit an abstract, but you cannot pay the minimum deposit at this time, please contact us for a registration link which will allow you to register without a deposit. We hope these services are helpful during this difficult time.
Lung development is governed by epithelial-mesenchymal interactions. These pathways are recapitulated during injury and repair. This conference will focus on understanding key processes underlying lung development, injury and repair in the context of age, environment and species, with the hope of better understanding disease development and to discover novel therapeutic approaches.
We will highlight critical issues on lung epithelial biology such as stem cells and regenerative medicine, while expanding sessions to encompass themes such as single cell analytical approaches, cell-cell communication, dissect the biological distinctions mesenchymal proliferation as a repair mechanism and fibrosis; present the impact of new tools in single cell analysis on understanding lung development, repair, and disease; and characterize epithelial-mesenchymal interrelationships that maintain lung homeostasis and orchestrate repair and regeneration. The entire program has been designed to achieve a better understanding of the key clinical research issues and how they relate to basic mechanistic investigation.
Key Sessions
- Keynote and Emerging Topics
- Monogenic lung diseases
- Mechanotransduction in lung development and fibrosis
- Novel in vivo and in vitro models of IPF
- Stem cell niche interactions in lung health and disease
- In vivo and in vitro models of lung development
- Aging and Lung Fibrosis
Student Offer
Take advantage of this fantastic opportunity for students! Fully paying academics can bring a student for only $890. Unfortunately, Postdocs are not eligible. Both registration packages include; accommodation for the 14, 15, 16 February 2022 (on a shared basis for students) and a food and beverage package for the conference period. Once registered, please contact Emily Meen to obtain a special registration link for your student.
Confirmed Invited Speakers
Wellington Cardoso (Columbia University)
Brent Carter (University of Alabama at Birmingham)
Rachel Chambers (University College London)
Jichao Chen (MD Anderson Cancer Center)
SIGNALING ROLES OF ALVEOLAR TYPE 1 CELLS TOWARD THE LUNG MESENCHYME
Tushar Desai (Stanford Child Health Research Institute)
Amy Firth (University of Southern California)
Susanne Herold (Justus Liebig University Giessen)
Gisli Jenkins (University of Nottingham)
Carla Kim (Boston Children's Hospital / Harvard Medical School)
ORGANOID MODELING OF LUNG DISEASE AND LUNG CANCER
Melanie Koenigshoff (University of Colorado Denver)
LUNG EPITHELIAL CELLS AND THE FIBROTIC NICHE
Vibha Lama (University of Michigan)
Joo-Hyeon Lee (University of Cambridge)
Yuru Liu (University of Illinois at Chicago)
REGULATION OF ALVEOLAR TYPE II CELLS DURING LUNG HOMEOSTASIS AND REPAIR
Edward Morrisey (University of Pennsylvania)
Paul Noble (Cedars-Sinai Medical Center)
Ana Pardo-Saganta (CIMA - University of Navarra)
Jin-Ah Park (Harvard University)
COLLECTIVE EPITHELIAL CELL MIGRATION BY THE UNJAMMING TRANSITION (UJT) IN THE ABSENCE OF THE EPITHELIAL–MESENCHYMAL TRANSITION (EMT)
Tien Peng (University of California, San Francisco)
OF MICE AND MEN: SPECIES-SPECIFIC MECHANISMS OF BASAL CELL METAPLASIA IN THE ALVEOLI
Jayaraj Rajagopal (Harvard University)
FUNCTIONAL DIVERSITY IN THE AIRWAY EPITHELIUM
Steve Rowe (University of Alabama at Birmingham)
David Schwartz (University of Colorado)
IDIOPATHIC PULMONARY FIBROSIS: A GENETIC AND EPIGENETIC DISEASE INITIATED BY MUC5B
Dean Sheppard (University of California, San Francisco)
PULMONARY FIBROSIS: HOW EPITHELIAL CELLS AND FIBROBLASTS DRIVE EACH OTHER MAD
Debora Sinner (Cincinnati Children’s Hospital Medical Center)
Jason Spence (University of Michigan)
Xin Sun (University of California, San Diego)
Nan Tang (National Institute of Biological Sciences, Beijing)
Victor Thannickal (University of Alabama at Birmingham)
Daniel Tschumperlin (Mayo Clinic)
DOPAMINE SIGNALING IN FIBROSIS RESOLUTION
Jeffrey Whitsett (Cincinnati Children’s Hospital Medical Center)
Rui Zhao (Genomics Institute of the Novartis Research Foundation)
Target Audience
- Lung developmental biologists
- Stem cell researchers
- Fibrosis researchers
- Pulmonary fibrosis researchers
Educational Need
It is known that lung developmental pathways are reactivated in pulmonary fibrosis, yet few if any meetings bring lung developmental biologists and researchers studying lung fibrosis together. This meeting will provide a unique opportunity to bring these 2 fields together.